MicroRNA Targets in Cancer Research Using TaqMan® MicroRNA ABC Purification Kit
2,886 views · Published 5 June 2013 · 4:31 · Indexed 24 October 2026
Channel: Thermo Fisher Scientific · 2013 · Science & Technology
Learn more: http://bit.ly/13Goizp Dr. Leendert Looijenga at the Erasmus Medical Center in the Netherlands focuses his research on the optimization of diagnosis and treatment, including follow up, of patients with a germ cell tumor. Early diagnosis, before development of an occult cancer, is of primary interest, as well as optimal long term follow-up. The research goal is analysis of pathogenesis involved in cancer of the gonads, and identify risk groups for cancer, optimization for diagnostic procedures, follow up, identify treatment sensitivity or resistance. The focus on DNA, mRNA, miRNA and protein level is to identify the earliest changes in the development of cancer. The miRNAs identified are expressed at the earliest stage of cancer and therefore the best targets to analyze. Dr. Looijenga's team has developed a pipeline for detection of miRNA in body fluids, including the TaqMan miRNA ABC Purification Kit.
More from this channel
-
1:58
Attune™ Acoustic Focusing Cytometer
-
1:40
re:sponsibility - Greener Product Alternatives
-
3:08
Women and Technology Summit (WITI), San Jose, CA. Sept 2010
-
42:22
Still leaving microbial identification to chance?
-
2:01
Gibco. Every little thing matters: Kathleen Weiss
-
1:43
Gibco. Every little thing matters: Deric Richardson
-
2:26
Gibco. Every little thing matters: Henry Jackson
-
7:47
Mutations- Greater Coverage Study at AACR